134 related articles for article (PubMed ID: 37170629)
1. X-ray sensitive selenium-containing Ru complexes sensitize nasopharyngeal carcinoma cells for radio/chemotherapy.
Shi C; Yuan Z; Liu T; Chan L; Chen T; Zhao J
J Mater Chem B; 2023 Jun; 11(24):5607-5618. PubMed ID: 37170629
[TBL] [Abstract][Full Text] [Related]
2. Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling.
Lai H; Zeng D; Liu C; Zhang Q; Wang X; Chen T
Biomaterials; 2019 Oct; 219():119377. PubMed ID: 31374478
[TBL] [Abstract][Full Text] [Related]
3. Selenium-ruthenium complex blocks H1N1 influenza virus-induced cell damage by activating GPx1/TrxR1.
Li Y; Chen D; Su J; Chen M; Chen T; Jia W; Zhu B
Theranostics; 2023; 13(6):1843-1859. PubMed ID: 37064873
[No Abstract] [Full Text] [Related]
4. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
Xu Y; Lai H; Pan S; Pan L; Liu T; Yang Z; Chen T; Zhu X
Biomaterials; 2024 Mar; 305():122452. PubMed ID: 38154440
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Targeted Selenium Nanoparticles Sensitize Cancer Cells to Continuous γ Radiation to Achieve Synergetic Chemo-Radiotherapy.
Chan L; He L; Zhou B; Guan S; Bo M; Yang Y; Liu Y; Liu X; Zhang Y; Xie Q; Chen T
Chem Asian J; 2017 Dec; 12(23):3053-3060. PubMed ID: 28892302
[TBL] [Abstract][Full Text] [Related]
6. A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.
Deng Z; Yu L; Cao W; Zheng W; Chen T
Chem Commun (Camb); 2015 Feb; 51(13):2637-40. PubMed ID: 25574525
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of mitochondrial ROS accumulation and radiotherapeutic efficacy using a Gd-doped titania nanosensitizer.
Chen Y; Li N; Wang J; Zhang X; Pan W; Yu L; Tang B
Theranostics; 2019; 9(1):167-178. PubMed ID: 30662560
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells.
Meng DF; Guo LL; Peng LX; Zheng LS; Xie P; Mei Y; Li CZ; Peng XS; Lang YH; Liu ZJ; Wang MD; Xie DH; Shu DT; Hu H; Lin ST; Li HF; Luo FF; Sun R; Huang BJ; Qian CN
Biochem Biophys Res Commun; 2020 Jun; 527(3):770-777. PubMed ID: 32446561
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species-mediated mitochondrial dysfunction is involved in apoptosis in human nasopharyngeal carcinoma CNE cells induced by Selaginella doederleinii extract.
Liu H; Peng H; Ji Z; Zhao S; Zhang Y; Wu J; Fan J; Liao J
J Ethnopharmacol; 2011 Oct; 138(1):184-91. PubMed ID: 21924341
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium-Based Metal-Organic Nanoradiosensitizers Enhance Radiotherapy by Combining ROS Generation and CO Gas Release.
Dai Q; Wang L; Ren E; Chen H; Gao X; Cheng H; An Y; Chu C; Liu G
Angew Chem Int Ed Engl; 2022 Dec; 61(50):e202211674. PubMed ID: 36184566
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation.
Deng Z; Yu L; Cao W; Zheng W; Chen T
ChemMedChem; 2015 Jun; 10(6):991-8. PubMed ID: 25914192
[TBL] [Abstract][Full Text] [Related]
12. Enhanced melanoma cell-killing by combined phototherapy/radiotherapy using a mesoporous platinum nanostructure.
Salehi F; Daneshvar F; Karimi M; Dehdari Vais R; Mosleh-Shirazi MA; Sattarahmady N
Photodiagnosis Photodyn Ther; 2019 Dec; 28():300-307. PubMed ID: 31606514
[TBL] [Abstract][Full Text] [Related]
13. GSH triggered intracellular aggregated-cisplatin-loaded iron oxide nanoparticles for overcoming cisplatin resistance in nasopharyngeal carcinoma.
Bejjanki NK; Xu H; Xie M
J Biomater Appl; 2021 Jul; 36(1):45-54. PubMed ID: 33402041
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
[TBL] [Abstract][Full Text] [Related]
15. Alleviating the hypoxic tumor microenvironment with MnO
Pi F; Deng X; Xue Q; Zheng L; Liu H; Yang F; Chen T
J Nanobiotechnology; 2023 Mar; 21(1):90. PubMed ID: 36922836
[TBL] [Abstract][Full Text] [Related]
16. A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumor Radiotherapy.
Jiang X; Jiang X; Wu D; Xie W; Liu X; Zheng J
Int J Nanomedicine; 2024; 19():709-725. PubMed ID: 38283195
[TBL] [Abstract][Full Text] [Related]
17. A novel Rhein derivative: Activation of Rac1/NADPH pathway enhances sensitivity of nasopharyngeal carcinoma cells to radiotherapy.
Su Z; Li Z; Wang C; Tian W; Lan F; Liang D; Li J; Li D; Hou H
Cell Signal; 2019 Feb; 54():35-45. PubMed ID: 30463023
[TBL] [Abstract][Full Text] [Related]
18. A novel multifunctional nanocomposite C225-conjugated Fe3O4/Ag enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy.
Zhao D; Sun X; Tong J; Ma J; Bu X; Xu R; Fan R
Acta Biochim Biophys Sin (Shanghai); 2012 Aug; 44(8):678-84. PubMed ID: 22710262
[TBL] [Abstract][Full Text] [Related]
19. A nuclear-targeted titanium dioxide radiosensitizer for cell cycle regulation and enhanced radiotherapy.
Pan W; Gong S; Wang J; Yu L; Chen Y; Li N; Tang B
Chem Commun (Camb); 2019 Jul; 55(56):8182-8185. PubMed ID: 31241064
[TBL] [Abstract][Full Text] [Related]
20. Enhancing anti-tumor effect of ultrasensitive bimetallic RuCu nanoparticles as radiosensitizers with dual enzyme-like activities.
Hu B; Xiao X; Chen P; Qian J; Yuan G; Ye Y; Zeng L; Zhong S; Wang X; Qin X; Yang Y; Pan Y; Zhang Y
Biomaterials; 2022 Nov; 290():121811. PubMed ID: 36201948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
